Portfolio Holdings Detail for ISIN IE000T9EOCL3
| Stock Name / Fund | iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) |
| Issuer | |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | EWSA(USD) Euronext Amsterdam |
Holdings detail for SLNO
| Stock Name | Soleno Therapeutics Inc |
| Ticker | SLNO(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US8342032005 |
Show aggregate SLNO holdings
News associated with SLNO
- Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of “Buy” by Brokerages
- Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have been assigned an average rating of “Buy” from the twelve research firms that are presently covering the firm, Marketbeat reports. Eleven analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year […] - 2025-08-28 02:24:50
- Notable Friday Option Activity: CSCO, SLNO, MDB
- Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cisco Systems Inc (Symbol: CSCO), where a total volume of 148,281 contracts has been traded thus far today, a contract volume which is representative of approxim - 2025-08-15 16:27:16
- Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $108.70 Consensus Price Target from Brokerages
- Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) has received a consensus recommendation of “Buy” from the eleven analysts that are presently covering the company, Marketbeat.com reports. Ten investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target […] - 2025-08-06 02:30:59
- Soleno Therapeutics (NASDAQ:SLNO) Raised to “Hold” at Wall Street Zen
- Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday. Several other analysts also recently weighed in on the company. HC Wainwright restated a “buy” rating and set a $100.00 target price on shares of Soleno Therapeutics […] - 2025-07-28 04:00:47
- Arizona State Retirement System Has $527,000 Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
- Arizona State Retirement System boosted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,380 shares of the company’s stock after purchasing an additional 620 shares during the […] - 2025-07-22 07:43:03
- Arizona State Retirement System Has $527,000 Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
- Arizona State Retirement System boosted its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,380 shares of the company’s stock after buying an additional 620 shares during […] - 2025-07-22 06:56:57
- Soleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $121.00
- Soleno Therapeutics (NASDAQ:SLNO – Free Report) had its target price lifted by Robert W. Baird from $105.00 to $121.00 in a research note released on Friday morning,Benzinga reports. They currently have an outperform rating on the stock. A number of other equities analysts have also weighed in on SLNO. Stifel Nicolaus increased their target price […] - 2025-07-14 03:30:49
- Avior Wealth Management LLC Grows Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
- Avior Wealth Management LLC grew its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 72.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,410 shares of the company’s stock after buying an additional 1,437 shares during […] - 2025-06-24 04:52:53
- Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $106.78 Average Target Price from Brokerages
- Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have earned an average recommendation of “Buy” from the nine research firms that are currently covering the firm, MarketBeat.com reports. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price […] - 2025-06-17 03:08:55
- California State Teachers Retirement System Has $988,000 Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
- California State Teachers Retirement System boosted its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 23.6% in the fourth quarter, HoldingsChannel reports. The firm owned 21,977 shares of the company’s stock after acquiring an additional 4,201 shares during the period. California State Teachers Retirement System’s holdings in Soleno Therapeutics were worth […] - 2025-06-11 05:04:47
- UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
- UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 24.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,504 shares of the company’s stock […] - 2025-06-10 04:20:47
- Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Bought by ProShare Advisors LLC
- ProShare Advisors LLC lifted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 64.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,206 shares of the company’s stock after buying an additional 2,836 shares during […] - 2025-05-30 05:06:50
- Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Average Recommendation of “Buy” from Analysts
- Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) has earned an average recommendation of “Buy” from the nine research firms that are covering the stock, MarketBeat reports. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among […] - 2025-05-20 02:31:41
- Deutsche Bank AG Purchases 36,971 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)
- Deutsche Bank AG grew its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 44.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 119,455 shares of the company’s stock after buying an additional 36,971 shares during the period. Deutsche Bank […] - 2025-05-19 05:07:01
- BNP Paribas Financial Markets Purchases New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
- BNP Paribas Financial Markets purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 71,320 shares of the company’s stock, valued at approximately $3,206,000. BNP Paribas Financial Markets owned 0.17% of Soleno Therapeutics […] - 2025-05-16 05:08:56
- Reviewing Soleno Therapeutics (NASDAQ:SLNO) & Guided Therapeutics (OTCMKTS:GTHP)
- Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) and Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends. Profitability This table compares Soleno Therapeutics and Guided […] - 2025-04-29 02:22:53
- Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Purchased by Legal & General Group Plc
- Legal & General Group Plc grew its stake in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 23,471 shares of the company’s stock after purchasing an additional 1,983 shares during the quarter. Legal & General Group Plc’s holdings in Soleno Therapeutics were worth […] - 2025-04-28 04:56:52
- Brokerages Set Soleno Therapeutics, Inc. (NASDAQ:SLNO) PT at $104.67
- Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) has been assigned an average rating of “Buy” from the ten brokerages that are presently covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12 month price […] - 2025-04-28 02:39:09
- Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $94.57 Consensus PT from Brokerages
- Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have been assigned an average recommendation of “Buy” from the nine ratings firms that are presently covering the company, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average […] - 2025-04-03 02:35:01
- Soleno Therapeutics (NASDAQ:SLNO) Sees Strong Trading Volume Following Analyst Upgrade
- Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) saw unusually-high trading volume on Monday after HC Wainwright raised their price target on the stock from $70.00 to $100.00. HC Wainwright currently has a buy rating on the stock. Approximately 891,497 shares traded hands during mid-day trading, an increase of 40% from the previous […] - 2025-04-01 02:54:47
- Stocks Finish Lower as Tariffs Cloud the Economic Outlook
- The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.37%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.59%. June E-mini S&P futures (ESM25 ) are down -0.32%, and June E-mini Nasdaq futures... - 2025-03-28 10:31:16
- Swiss National Bank Boosts Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
- Swiss National Bank lifted its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 27.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 45,900 shares of the company’s stock after purchasing an additional 9,900 shares during the quarter. Swiss National […] - 2025-03-28 06:28:50
- Stocks Trade Mixed on Strong Economic Data, Lingering Tariff Uncertainty
- The S&P 500 Index ($SPX ) (SPY ) today is down -0.12%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.25%. June E-mini S&P futures (ESM25 ) are down -0.07%, and June E-mini Nasdaq futures... - 2025-03-27 19:46:46
- Stocks Bounce Back as Investors Shrug Off Auto Tariffs
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.32%. June E-mini S&P futures (ESM25 ) are up +0.29%, and June E-mini Nasdaq futures... - 2025-03-27 18:09:37
- Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Rating of “Buy” from Brokerages
- Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have received an average recommendation of “Buy” from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month target […] - 2025-03-06 05:21:27
- Soleno Therapeutics (NASDAQ:SLNO) Earns “Buy” Rating from HC Wainwright
- Soleno Therapeutics (NASDAQ:SLNO – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a report issued on Monday,Benzinga reports. They presently have a $70.00 target price on the stock. HC Wainwright’s price objective would indicate a potential upside of 57.52% from the company’s previous close. A number of other […] - 2025-03-05 05:04:52
- Allspring Global Investments Holdings LLC Decreases Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)
- Allspring Global Investments Holdings LLC trimmed its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Free Report) by 9.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 128,028 shares of the company’s stock after selling 13,396 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Soleno Therapeutics were worth $5,755,000 […] - 2025-02-20 06:24:48
- Soleno Therapeutics (NASDAQ:SLNO) Upgraded at Lifesci Capital
- Lifesci Capital upgraded shares of Soleno Therapeutics (NASDAQ:SLNO – Free Report) to a strong-buy rating in a research report report published on Tuesday morning,Zacks.com reports. Lifesci Capital also issued estimates for Soleno Therapeutics’ Q4 2024 earnings at ($0.37) EPS, Q1 2025 earnings at ($1.67) EPS, Q2 2025 earnings at ($1.13) EPS, Q3 2025 earnings at […] - 2025-02-07 06:36:55
iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) SLNO holdings
| Date | Number of SLNO Shares Held | Base Market Value of SLNO Shares | Local Market Value of SLNO Shares | Change in SLNO Shares Held | Change in SLNO Base Value | Current Price per SLNO Share Held | Previous Price per SLNO Share Held |
|---|
| 2025-11-27 (Thursday) | 309 | USD 15,311 | USD 15,311 | 0 | USD 0 | USD 49.5502 | USD 49.5502 |
| 2025-11-26 (Wednesday) | 309 | USD 15,311 | USD 15,311 | 0 | USD -68 | USD 49.5502 | USD 49.7702 |
| 2025-11-25 (Tuesday) | 309 | USD 15,379 | USD 15,379 | 0 | USD 1,193 | USD 49.7702 | USD 45.9094 |
| 2025-11-24 (Monday) | 309 | USD 14,186 | USD 14,186 | 0 | USD 247 | USD 45.9094 | USD 45.11 |
| 2025-11-21 (Friday) | 309 | USD 13,939 | USD 13,939 | 0 | USD 49 | USD 45.11 | USD 44.9515 |
| 2025-11-20 (Thursday) | 309 | USD 13,890 | USD 13,890 | 0 | USD -633 | USD 44.9515 | USD 47 |
| 2025-11-19 (Wednesday) | 309 | USD 14,523 | USD 14,523 | 0 | USD -476 | USD 47 | USD 48.5405 |
| 2025-11-18 (Tuesday) | 309 | USD 14,999 | USD 14,999 | 0 | USD 399 | USD 48.5405 | USD 47.2492 |
| 2025-11-17 (Monday) | 309 | USD 14,600 | USD 14,600 | 0 | USD -671 | USD 47.2492 | USD 49.4207 |
| 2025-11-14 (Friday) | 309 | USD 15,271 | USD 15,271 | 0 | USD 640 | USD 49.4207 | USD 47.3495 |
| 2025-11-13 (Thursday) | 309 | USD 14,631 | USD 14,631 | 0 | USD -118 | USD 47.3495 | USD 47.7314 |
| 2025-11-12 (Wednesday) | 309 | USD 14,749 | USD 14,749 | 0 | USD -299 | USD 47.7314 | USD 48.699 |
| 2025-11-11 (Tuesday) | 309 | USD 15,048 | USD 15,048 | 22 | USD 1,757 | USD 48.699 | USD 46.3101 |
| 2025-11-10 (Monday) | 287 | USD 13,291 | USD 13,291 | 0 | USD -399 | USD 46.3101 | USD 47.7003 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of SLNO by for IE000T9EOCL3
Show aggregate share trades of SLNO| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-11-11 | BUY | 22 | | | 48.699* | | 71.49 |
| 2025-09-25 | SELL | -235 | 62.720 | 65.200 | 64.952 | USD -15,264 | 73.73 Profit of 2,062 on sale |
| 2025-07-31 | BUY | 41 | 86.470 | 87.570 | 87.460 | USD 3,586 | 72.88 |
| 2025-06-17 | BUY | 41 | 77.600 | 77.870 | 77.843 | USD 3,192 | 68.13 |
| 2025-05-30 | BUY | 310 | 73.350 | 75.275 | 75.083 | USD 23,276 | 66.28 |
| 2025-05-14 | BUY | 52 | 73.460 | 75.430 | 75.233 | USD 3,912 | 64.04 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of SLNO
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 608,865 | 0 | 745,858 | 81.6% |
| 2025-09-18 | 1,241,903 | 5,301 | 1,548,867 | 80.2% |
| 2025-09-17 | 518,877 | 0 | 1,080,255 | 48.0% |
| 2025-09-16 | 330,132 | 45 | 1,290,842 | 25.6% |
| 2025-09-15 | 280,200 | 0 | 950,973 | 29.5% |
| 2025-09-12 | 407,554 | 50 | 1,253,802 | 32.5% |
| 2025-09-11 | 440,183 | 17,403 | 1,092,275 | 40.3% |
| 2025-09-10 | 1,588,942 | 88,984 | 4,369,449 | 36.4% |
| 2025-09-09 | 183,968 | 0 | 395,052 | 46.6% |
| 2025-09-08 | 187,858 | 0 | 270,198 | 69.5% |
| 2025-09-05 | 143,982 | 318 | 247,257 | 58.2% |
| 2025-09-04 | 318,953 | 1,806 | 490,398 | 65.0% |
| 2025-09-03 | 206,704 | 0 | 361,809 | 57.1% |
| 2025-09-02 | 327,081 | 9,078 | 458,596 | 71.3% |
| 2025-08-29 | 181,245 | 488 | 299,741 | 60.5% |
| 2025-08-28 | 227,190 | 1,400 | 366,571 | 62.0% |
| 2025-08-27 | 354,211 | 0 | 469,381 | 75.5% |
| 2025-08-26 | 278,825 | 0 | 541,503 | 51.5% |
| 2025-08-25 | 183,662 | 978 | 426,421 | 43.1% |
| 2025-08-22 | 271,697 | 1,335 | 466,636 | 58.2% |
| 2025-08-21 | 411,708 | 618 | 577,052 | 71.3% |
| 2025-08-20 | 376,847 | 0 | 653,201 | 57.7% |
| 2025-08-19 | 239,900 | 0 | 600,569 | 39.9% |
| 2025-08-18 | 356,047 | 17,859 | 784,490 | 45.4% |
| 2025-08-15 | 1,511,407 | 11,609 | 3,088,692 | 48.9% |
| 2025-08-14 | 677,905 | 200,657 | 1,137,359 | 59.6% |
| 2025-08-13 | 617,389 | 338,747 | 970,535 | 63.6% |
| 2025-08-12 | 320,068 | 158,746 | 411,318 | 77.8% |
| 2025-08-11 | 489,908 | 198,345 | 807,185 | 60.7% |
| 2025-08-08 | 265,898 | 0 | 354,107 | 75.1% |
| 2025-08-07 | 376,234 | 105 | 548,371 | 68.6% |
| 2025-08-06 | 129,954 | 20 | 387,938 | 33.5% |
| 2025-08-05 | 197,763 | 372 | 317,736 | 62.2% |
| 2025-08-04 | 131,501 | 245 | 245,307 | 53.6% |
| 2025-08-01 | 236,341 | 0 | 441,054 | 53.6% |
| 2025-07-31 | 259,440 | 0 | 641,494 | 40.4% |
| 2025-07-30 | 217,198 | 57 | 642,882 | 33.8% |
| 2025-07-29 | 238,663 | 0 | 589,016 | 40.5% |
| 2025-07-28 | 207,918 | 0 | 536,745 | 38.7% |
| 2025-07-25 | 226,637 | 91 | 446,497 | 50.8% |
| 2025-07-24 | 214,977 | 274 | 395,247 | 54.4% |
| 2025-07-23 | 220,284 | 0 | 305,239 | 72.2% |
| 2025-07-22 | 266,909 | 485 | 472,286 | 56.5% |
| 2025-07-21 | 240,868 | 45 | 385,470 | 62.5% |
| 2025-07-18 | 207,760 | 86 | 389,270 | 53.4% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.